Rusnati, M <br/><br/>
Estro-progestinic replacement therapy modulates the levels of basic fibroblast growth factor (bFGF) in postmenopausal endometrium.  [electronic resource] 

 -  Gynecologic oncology  Jan 1993 
 - 88-93 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0090-8258 
<br/><br/><label>Standard No.: </label>10.1006/gyno.1993.1014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--metabolism<br/>Adult<br/>Aged<br/>Blotting, Western<br/>Endometrial Neoplasms--metabolism<br/>Endometrium--metabolism<br/>Estrogen Replacement Therapy<br/>Female<br/>Fibroblast Growth Factor 2--metabolism<br/>Humans<br/>Menopause--metabolism<br/>Middle Aged<br/>Plasminogen Activators--metabolism